These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 18109292)

  • 1. The use of nitrogen mustard in Hodgkin's disease and lymphosarcoma.
    MEYER AH; OVERMILLER WC
    Ann Intern Med; 1949 Feb; 30(2):381-6. PubMed ID: 18109292
    [No Abstract]   [Full Text] [Related]  

  • 2. Nitrogen mustard therapy; the use of methyl bis (B chloroethyl) amine hydrochloride in Hodgkin's disease, leukemia, lymphosarcoma and cancer of the lung.
    BEN-ASHER S
    Am J Med Sci; 1949 Feb; 217(2):162-8. PubMed ID: 18109277
    [No Abstract]   [Full Text] [Related]  

  • 3. Nitrogen-mustard therapy for Hodgkin's disease, lymphosarcoma, the leukemias, and other disorders.
    WINTROBE MM; HUGULEY CM
    Cancer; 1948 Sep; 1(3):357-82. PubMed ID: 18887904
    [No Abstract]   [Full Text] [Related]  

  • 4. [Nitrogen mustard in the treatment of Hodgkin's disease, lymphosarcoma, leukemia and related diseases].
    de LORENZO J; JANNINI P
    Arq Clin (Rio De J); 1951 Mar; 12(3):141-61. PubMed ID: 14847898
    [No Abstract]   [Full Text] [Related]  

  • 5. Nitrogen mustards in the treatment of Hodgkin's disease and lymphosarcoma.
    SHERRY M
    South Med J; 1948 Feb; 41(2):118-29. PubMed ID: 18898249
    [No Abstract]   [Full Text] [Related]  

  • 6. [Effect of methyl-bis (beta-chloroethyl)amine hydrochloride on Hodgkin's disease, lymphosarcoma, leukemia and neoplasms].
    LEVI M; MENE G; FERRI A
    Riv Patol Clin; 1951 Jan; 6(1):1-58. PubMed ID: 14834735
    [No Abstract]   [Full Text] [Related]  

  • 7. The partition of radio-phosphorus (P32) in blood, urine and tumor tissue in patients with Hodgkin's disease and lymphosarcoma before and after treatment with nitrogen mustard [methyl bis (beta-chloroethyl) amine].
    MASOUREDIS SP; LOW-BEER BV; BIERMAN HR; CHERNEY LS; SHIMKIN MB
    J Natl Cancer Inst; 1950 Oct; 11(2):289-300. PubMed ID: 14795186
    [No Abstract]   [Full Text] [Related]  

  • 8. Nitrogen mustard therapy; use of methyl-bis (beta-chloroethyl) amine hydrochloride and tris (beta-chloroethyl) amine hydrochloride for Hodgkin's disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders.
    GOODMAN LS; WINTROBE MM
    J Am Med Assoc; 1946 Sep; 132():126-32. PubMed ID: 20997191
    [No Abstract]   [Full Text] [Related]  

  • 9. [The use of nitrogen mustard in the treatment of lymphatic diseases of a malignant type].
    RABENKO J; CORREA URQUIZA LM
    Prensa Med Argent; 1959 Oct; 46():2549-54. PubMed ID: 14435621
    [No Abstract]   [Full Text] [Related]  

  • 10. Nitrogen mustard as a therapeutic agent for Hodgkin's disease, lymphosarcoma and leukemia.
    WINTROBE MM; HUGULEY CM
    Ann Intern Med; 1947 Oct; 27(4):529-40. PubMed ID: 20268426
    [No Abstract]   [Full Text] [Related]  

  • 11. Nitrogen mustards in the treatment of neoplastic disease.
    KARNOFSKY DA
    Adv Intern Med; 1950; 4():1-75. PubMed ID: 14770961
    [No Abstract]   [Full Text] [Related]  

  • 12. [Results obtained with the use of chlorambucil in the treatment of malignant lymphopathies].
    RABENKO J
    Sem Med; 1961 Jul; 119():378-80. PubMed ID: 14489588
    [No Abstract]   [Full Text] [Related]  

  • 13. The principles of radiation therapy of lymphoblastoma.
    ABOU SINNA I
    J Egypt Med Assoc; 1951; 34(5):13-8. PubMed ID: 14861882
    [No Abstract]   [Full Text] [Related]  

  • 14. [Nitrogen mustard therapy of various cases of malignant lymphogranuloma and lymphosarcoma].
    NARDI FL
    Accad Medica; 1952 Apr; 67(4):169-77. PubMed ID: 12984986
    [No Abstract]   [Full Text] [Related]  

  • 15. Nitrogen mustard therapy in Hodgkin's disease, lympho-reticulosarcomatosis and lymphatic leukaemia.
    KIELER J
    Acta radiol; 1951 Dec; 36(6):461-8. PubMed ID: 14902587
    [No Abstract]   [Full Text] [Related]  

  • 16. Nitrogen mustard in the treatment of Hodgkin's disease; a case report with discussion.
    SCHNEIDER M; POTH EJ; LEVIN WC
    Tex Rep Biol Med; 1948; 6(1):117-22. PubMed ID: 18904908
    [No Abstract]   [Full Text] [Related]  

  • 17. LONG TERM RESULTS ACHIEVED WITH THE USE OF ALKYLATING AGENTS IN MALIGNANT LYMPHOMA AND HODGKIN'S DISEASE.
    PAPAC RJ; WOOD DA
    Acta Unio Int Contra Cancrum; 1964; 20():377-9. PubMed ID: 14151934
    [No Abstract]   [Full Text] [Related]  

  • 18. [Naphthyl-chloroethylamine therapy of Hodgkin's disease and allied forms].
    BARENGHI G
    Accad Medica; 1950 Dec; 65(12):506-27. PubMed ID: 14856512
    [No Abstract]   [Full Text] [Related]  

  • 19. [Nitrogen mustard (DEMA) in the treatment of Hodgkin's disease].
    VARGAS Y VARGAS L; SOTO AR
    Bol Med Hosp Infant Mex; 1947; 4(5):563-76. PubMed ID: 18904675
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical experiences with nitrogen mustard in Hodgkin's disease.
    HOFMEYR HO
    S Afr Med J; 1947 Mar; 21(6):195-8. PubMed ID: 20293281
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.